News
Zepbound beats Wegovy for weight loss
Digest more
Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...
A new federal ruling means that patients will no longer have access to cheaper versions of Eli Lilly weight loss and diabetes ...
While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...
Digital programs incorporating behavioral therapy led to solid reductions in body weight, and did so at lower drug doses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results